KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹40 Cr | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr |
What is the latest Consolidated Net Profit of KWALITY PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹40 Cr |
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹120 Cr |
| Mar2022 | ₹15 Cr |
How is Consolidated Net Profit of KWALITY PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹40 Cr | 67.44 | |
| Mar2025 | ₹24 Cr | 22.83 | |
| Mar2024 | ₹19 Cr | -83.85 | |
| Mar2023 | ₹120 Cr | 692.23 | |
| Mar2022 | ₹15 Cr | - | |
Compare Consolidated Net Profit of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,460.3 Cr | 27.5% | 22.9% | 203.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 27.5% |
22.9% |
203.5% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses